Intensive insulin therapy in critically ill patients
- PMID: 11794168
- DOI: 10.1056/NEJMoa011300
Intensive insulin therapy in critically ill patients
Abstract
Background: Hyperglycemia and insulin resistance are common in critically ill patients, even if they have not previously had diabetes. Whether the normalization of blood glucose levels with insulin therapy improves the prognosis for such patients is not known.
Methods: We performed a prospective, randomized, controlled study involving adults admitted to our surgical intensive care unit who were receiving mechanical ventilation. On admission, patients were randomly assigned to receive intensive insulin therapy (maintenance of blood glucose at a level between 80 and 110 mg per deciliter [4.4 and 6.1 mmol per liter]) or conventional treatment (infusion of insulin only if the blood glucose level exceeded 215 mg per deciliter [11.9 mmol per liter] and maintenance of glucose at a level between 180 and 200 mg per deciliter [10.0 and 11.1 mmol per liter]).
Results: At 12 months, with a total of 1548 patients enrolled, intensive insulin therapy reduced mortality during intensive care from 8.0 percent with conventional treatment to 4.6 percent (P<0.04, with adjustment for sequential analyses). The benefit of intensive insulin therapy was attributable to its effect on mortality among patients who remained in the intensive care unit for more than five days (20.2 percent with conventional treatment, as compared with 10.6 percent with intensive insulin therapy, P=0.005). The greatest reduction in mortality involved deaths due to multiple-organ failure with a proven septic focus. Intensive insulin therapy also reduced overall in-hospital mortality by 34 percent, bloodstream infections by 46 percent, acute renal failure requiring dialysis or hemofiltration by 41 percent, the median number of red-cell transfusions by 50 percent, and critical-illness polyneuropathy by 44 percent, and patients receiving intensive therapy were less likely to require prolonged mechanical ventilation and intensive care.
Conclusions: Intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care unit.
Comment in
-
Hemodynamic and metabolic therapy in critically ill patients.N Engl J Med. 2001 Nov 8;345(19):1417-8. doi: 10.1056/NEJM200111083451910. N Engl J Med. 2001. PMID: 11794176 No abstract available.
-
Intensive insulin therapy reduced mortality and morbidity in critically ill patients.ACP J Club. 2002 May-Jun;136(3):81. doi: 10.7326/acpjc-2002-136-3-081. ACP J Club. 2002. PMID: 11985422 No abstract available.
-
Intensive insulin treatment reduced mortality and morbidity in critically ill patients.Evid Based Nurs. 2002 Apr;5(2):53. doi: 10.1136/ebn.5.2.53. Evid Based Nurs. 2002. PMID: 11995656 No abstract available.
-
Intensive insulin therapy in critically ill patients.N Engl J Med. 2002 May 16;346(20):1586-8; author reply 1586-8. doi: 10.1056/NEJM200205163462016. N Engl J Med. 2002. PMID: 12015401 No abstract available.
-
Intensive insulin therapy in critically ill patients.N Engl J Med. 2002 May 16;346(20):1586-8; author reply 1586-8. N Engl J Med. 2002. PMID: 12017160 No abstract available.
-
Intensive insulin therapy in critically ill patients.N Engl J Med. 2002 May 16;346(20):1586-8; author reply 1586-8. N Engl J Med. 2002. PMID: 12017161 No abstract available.
-
Intensive insulin therapy in critically ill patients.N Engl J Med. 2002 May 16;346(20):1586-8; author reply 1586-8. N Engl J Med. 2002. PMID: 12017162 No abstract available.
-
Benefits of intense glucose control in critically ill patients.Curr Surg. 2005 May-Jun;62(3):277-82. doi: 10.1016/j.cursur.2004.09.014. Curr Surg. 2005. PMID: 15890208 No abstract available.
-
Utility of intensive blood glucose control: generalizable to all general surgery patients?Nutr Clin Pract. 2004 Apr;19(2):181-3. doi: 10.1177/0115426504019002181. Nutr Clin Pract. 2004. PMID: 16215106 No abstract available.
-
Intensive insulin therapy in the medical ICU.N Engl J Med. 2006 May 11;354(19):2069-71; author reply 2069-71. N Engl J Med. 2006. PMID: 16696141 No abstract available.
-
Understanding the clinical issues involved with glycemic control in the intensive care unit.Curr Gastroenterol Rep. 2011 Aug;13(4):301-5. doi: 10.1007/s11894-011-0200-1. Curr Gastroenterol Rep. 2011. PMID: 21594635 No abstract available.
Similar articles
-
Intensive insulin therapy in the medical ICU.N Engl J Med. 2006 Feb 2;354(5):449-61. doi: 10.1056/NEJMoa052521. N Engl J Med. 2006. PMID: 16452557 Clinical Trial.
-
Intensive versus conventional glucose control in critically ill patients.N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625. Epub 2009 Mar 24. N Engl J Med. 2009. PMID: 19318384 Clinical Trial.
-
Tight Glycemic Control in Critically Ill Children.N Engl J Med. 2017 Feb 23;376(8):729-741. doi: 10.1056/NEJMoa1612348. Epub 2017 Jan 24. N Engl J Med. 2017. PMID: 28118549 Free PMC article. Clinical Trial.
-
Role of intravenous insulin therapy in critically ill patients.Endocr Pract. 2004 Mar-Apr;10 Suppl 2:17-20. doi: 10.4158/EP.10.S2.17. Endocr Pract. 2004. PMID: 15251636 Review.
-
Insulin therapy for the critically ill patient.Clin Cornerstone. 2003;5(2):56-63. doi: 10.1016/s1098-3597(03)90018-4. Clin Cornerstone. 2003. PMID: 12800480 Review.
Cited by
-
Hydrogen sulfide donor NaHS reduces organ injury in a rat model of pneumococcal pneumosepsis, associated with improved bio-energetic status.PLoS One. 2013 May 23;8(5):e63497. doi: 10.1371/journal.pone.0063497. Print 2013. PLoS One. 2013. PMID: 23717435 Free PMC article.
-
Management of post-transplant diabetes.Curr Diab Rep. 2013 Feb;13(1):121-9. doi: 10.1007/s11892-012-0346-8. Curr Diab Rep. 2013. PMID: 23188594 Review.
-
Impact of the triglyceride-glucose index on 28-day mortality in non-diabetic critically Ill patients with sepsis: a retrospective cohort analysis.BMC Infect Dis. 2024 Aug 5;24(1):785. doi: 10.1186/s12879-024-09711-4. BMC Infect Dis. 2024. PMID: 39103750 Free PMC article.
-
LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: the LOGIC-1 single-center, randomized, controlled clinical trial.Diabetes Care. 2013 Feb;36(2):188-94. doi: 10.2337/dc12-0584. Epub 2012 Sep 6. Diabetes Care. 2013. PMID: 22961576 Free PMC article. Clinical Trial.
-
The effect of stress hyperglycemıa seen ın acute ST-segment elevatıon ın myocardıal ınfarctıon on ın-hospıtal mortalıty.Ir J Med Sci. 2023 Jun;192(3):1109-1114. doi: 10.1007/s11845-022-03182-9. Epub 2022 Oct 10. Ir J Med Sci. 2023. PMID: 36217074
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical